The first dengue vaccine in India got the green signal, know who will get this dose and how?

What Is Qdenga Dengue Vaccine In India: The risk of dengue in India is increasing every year, especially during monsoon when the number of patients in hospitals increases rapidly. In such a situation, now a big relief news has come out that the country has got its first dengue vaccine. This step is being considered a big change not only in the direction of treatment but also in the direction of prevention. Let us tell you how this is a relief news for the country.

dengue related cases

According to government data, dengue cases have increased continuously in the last few years. While around 44 thousand cases were reported in 2020, in 2023 and 2024 this number crossed 2.3 lakh. Even in 2025, till November, more than 1.13 lakh cases have been registered. Experts believe that the actual figures may be even higher because many cases are not reported.

vaccine approved

Now TAK-003 vaccine, known as Qdenga, has been approved in India. It has been allowed to be used by the Expert Committee under the Drug Controller General of India for people between 4 to 60 years of age. This vaccine has been developed by Takeda Pharmaceutical Company Limited of Japan. The most important thing about this vaccine is that it does not matter whether one has had dengue before or not. This was a big challenge in the earlier vaccine. Qdenga is designed to protect against all four dengue virus serotypes, providing more comprehensive protection.

Read this also – Hot Water Benefits: To lose weight, you also drink hot water in the morning, does this hack really work?

How does it work?

It is given in two doses, between which there is a gap of three months. Clinical trials have found that this vaccine can provide protection for more than four years. The World Health Organization has also considered it useful in areas where the risk of dengue is high. Dr Archana Pate told TOI that India accounts for about one-third of the world’s population that is at risk of dengue. In such a situation, this vaccine can prove to be an important step for public health.

However, experts also believe that this is not a magical solution. The vaccine will definitely reduce the risk of dengue, but cannot eliminate it completely. The severity of dengue often depends on the body’s immune response, especially during a second infection. Another good news is that this vaccine will be produced in India only. For this, Takeda has partnered with Biological E. Limited of Hyderabad, due to which both its availability and price can improve in the coming time. Doctors clearly say that vaccine alone will not help. Preventing mosquitoes from breeding, maintaining cleanliness, timely testing and proper treatment, all these steps are equally important.

Read this also – Fenugreek water can be beneficial in Grade-1 fatty liver, know its surprising benefits

Disclaimer: This information is based on research studies and expert opinion. Do not consider this as a substitute for medical advice. Before adopting any new activity or exercise, please consult your doctor or relevant specialist.

Check out below Health Tools-
Calculate Your Body Mass Index (BMI)

Calculate The Age Through Age Calculator